{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T19:06:00Z","timestamp":1789931160003,"version":"4.0.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,20]]},"DOI":"10.7759\/cureus.116600","type":"journal-article","created":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T18:42:45Z","timestamp":1789929765000},"source":"Crossref","is-referenced-by-count":0,"title":["Antiphospholipid Syndrome as an Under-Recognized Cause of Ischemic Stroke in Older Adults: A Retrospective Case Series"],"prefix":"10.7759","author":[{"given":"Seyed Mostafa","family":"Razavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahika","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariami","family":"Gabadadze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaganesh","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poojitha Sushma","family":"Malla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"Elmasry Eldamarany Khalifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Abd Elazim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis S","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, et al.. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006, 4:295-306. 10.1111\/j.1538-7836.2006.01753.x","journal-title":"J Thromb Haemost"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/art.42624","article-title":"The 2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"75","author":"Barbhaiya M","year":"2023","unstructured":"Barbhaiya M, Zuily S, Naden R, et al.. The 2023 ACR\/EULAR antiphospholipid syndrome classification criteria. Arthritis Rheumatol. 2023, 75:1687-1702. 10.1002\/art.42624","journal-title":"Arthritis Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/art.40901","article-title":"The epidemiology of antiphospholipid syndrome: a population-based study","volume":"71","author":"Duarte-Garc\u00eda A","year":"2019","unstructured":"Duarte-Garc\u00eda A, Pham MM, Crowson CS, et al.. The epidemiology of antiphospholipid syndrome: a population-based study. Arthritis Rheumatol. 2019, 71:1545-1552. 10.1002\/art.40901","journal-title":"Arthritis Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204838","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients","volume":"74","author":"Cervera R","year":"2015","unstructured":"Cervera R, Serrano R, Pons-Estel GJ, et al.. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis. 2015, 74:1011-1018. 10.1136\/annrheumdis-2013-204838","journal-title":"Ann Rheum Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.120.030431","article-title":"Antiphospholipid antibody and recurrent ischemic stroke: a systematic review and meta-analysis","volume":"51","author":"Kim Y","year":"2020","unstructured":"Kim Y, Kim SY. Antiphospholipid antibody and recurrent ischemic stroke: a systematic review and meta-analysis. Stroke. 2020, 51:3728-3732. 10.1161\/STROKEAHA.120.030431","journal-title":"Stroke"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/bc.bc_67_23","article-title":"Primary antiphospholipid syndrome in the elderly: four strokes and mechanical thrombectomies until the diagnosis \u2014 a case report","volume":"10","author":"Anastasiadi A","year":"2024","unstructured":"Anastasiadi A, Bott C, Kitterer D, Roser E, Henkes H, B\u00e4zner H, Wolf ME. Primary antiphospholipid syndrome in the elderly: four strokes and mechanical thrombectomies until the diagnosis \u2014 a case report. Brain Circ. 2024, 10:184-187. 10.4103\/bc.bc_67_23","journal-title":"Brain Circ"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0268481","article-title":"Causes of ischemic stroke in young adults versus non-young adults: a multicenter hospital-based observational study","volume":"17","author":"Ohya Y","year":"2022","unstructured":"Ohya Y, Matsuo R, Sato N, et al.. Causes of ischemic stroke in young adults versus non-young adults: a multicenter hospital-based observational study. PLoS One. 2022, 17:e0268481. 10.1371\/journal.pone.0268481","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4247-3","article-title":"Stroke and antiphospholipid syndrome-antiphospholipid antibodies are a risk factor for an ischemic cerebrovascular event","volume":"38","author":"Ga\u0161per\u0161i\u010d N","year":"2019","unstructured":"Ga\u0161per\u0161i\u010d N, Zaletel M, Kobal J, et al.. Stroke and antiphospholipid syndrome-antiphospholipid antibodies are a risk factor for an ischemic cerebrovascular event. Clin Rheumatol. 2019, 38:379-384. 10.1007\/s10067-018-4247-3","journal-title":"Clin Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/09612033241266875","article-title":"Characteristics and prognosis of elderly-onset antiphospholipid syndrome: an observational cohort study","volume":"33","author":"Luo L","year":"2024","unstructured":"Luo L, Cai Q, Liu X, Yun Z, Li X, Yan R, Li C. Characteristics and prognosis of elderly-onset antiphospholipid syndrome: an observational cohort study. Lupus. 2024, 33:1034-1042. 10.1177\/09612033241266875","journal-title":"Lupus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams HP Jr","year":"1993","unstructured":"Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993, 24:35-41. 10.1161\/01.str.24.1.35","journal-title":"Stroke"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.5.576","article-title":"Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke","volume":"291","author":"Levine SR","year":"2004","unstructured":"Levine SR, Brey RL, Tilley BC, et al.. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA. 2004, 291:576-584. 10.1001\/jama.291.5.576","journal-title":"JAMA"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.107885","article-title":"Antiphospholipid antibodies as potential prognostic indicators of recurrent ischemic stroke","volume":"33","author":"Geng L","year":"2024","unstructured":"Geng L, Pan K, Xu Y, et al.. Antiphospholipid antibodies as potential prognostic indicators of recurrent ischemic stroke. J Stroke Cerebrovasc Dis. 2024, 33:107885. 10.1016\/j.jstrokecerebrovasdis.2024.107885","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2024.02.019","article-title":"Performance validation of the 2023 American College of Rheumatology\/European League Against Rheumatism antiphospholipid syndrome classification criteria in an antiphospholipid syndrome cohort","volume":"22","author":"Zhao Y","year":"2024","unstructured":"Zhao Y, Huang C, Zhou Y, et al.. Performance validation of the 2023 American College of Rheumatology\/European League Against Rheumatism antiphospholipid syndrome classification criteria in an antiphospholipid syndrome cohort. J Thromb Haemost. 2024, 22:1660-1674. 10.1016\/j.jtha.2024.02.019","journal-title":"J Thromb Haemost"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/10760296211002274","article-title":"Ischemic stroke in the young","volume":"27","author":"Berkman SA","year":"2021","unstructured":"Berkman SA, Song SS. Ischemic stroke in the young. Clin Appl Thromb Hemost. 2021, 27:10.1177\/10760296211002274","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.588151","article-title":"Who should rather undergo transesophageal echocardiography to determine stroke etiology: young or elderly stroke patients?","volume":"11","author":"Strecker C","year":"2020","unstructured":"Strecker C, G\u00fcnther F, Harloff A. Who should rather undergo transesophageal echocardiography to determine stroke etiology: young or elderly stroke patients?. Front Neurol. 2020, 11:588151. 10.3389\/fneur.2020.588151","journal-title":"Front Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou MG","year":"2019","unstructured":"Tektonidou MG, Andreoli L, Limper M, et al.. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis. 2019, 78:1296-1304. 10.1136\/annrheumdis-2019-215213","journal-title":"Ann Rheum Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-04-848333","article-title":"Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome","volume":"132","author":"Pengo V","year":"2018","unstructured":"Pengo V, Denas G, Zoppellaro G, et al.. Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome. Blood. 2018, 132:1365-1371. 10.1182\/blood-2018-04-848333","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7326\/M19-0291","article-title":"Rivaroxaban versus vitamin K antagonist in antiphospholipid syndrome: a randomized noninferiority trial","volume":"171","author":"Ordi-Ros J","year":"2019","unstructured":"Ordi-Ros J, S\u00e1ez-Comet L, P\u00e9rez-Conesa M, et al.. Rivaroxaban versus vitamin K antagonist in antiphospholipid syndrome: a randomized noninferiority trial. Ann Intern Med. 2019, 171:685-694. 10.7326\/M19-0291","journal-title":"Ann Intern Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14935","article-title":"Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis","volume":"18","author":"Zuily S","year":"2020","unstructured":"Zuily S, Cohen H, Isenberg D, et al.. Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2020, 18:2126-2137. 10.1111\/jth.14935","journal-title":"J Thromb Haemost"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/532462-antiphospholipid-syndrome-as-an-under-recognized-cause-of-ischemic-stroke-in-older-adults-a-retrospective-case-series","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T18:42:46Z","timestamp":1789929766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/532462-antiphospholipid-syndrome-as-an-under-recognized-cause-of-ischemic-stroke-in-older-adults-a-retrospective-case-series"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,20]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.116600","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,20]]}}}